KRAS and lymphangitis: In this study, we found that EGFR mutations were associated with GGO, KRAS mutations were associated with solid tumors that had low tendencies to metastasize to the lung and pleura, and ALK rearrangements were associated with lymph node involvement and lymphangitis.